Evidence map›Paper›PMID 38084192›Full record

ArticleCureus2023

Unveiling the Veil: Exploring Diabetic Retinopathy Awareness and Behaviors of the General Population of Hafr Al Batin, Saudi Arabia.

Farhan K Alswailmi

Open access · diamondAbstract read
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Farhan K AlswailmiDepartment of Pharmacy Practice, College of Pharmacy, University of Hafr Al Batin, Hafr Al Batin, SAU.
University of Hafr Al-Batin · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetic retinopathy (DR) is a potentially blinding complication of diabetes mellitus (DM). The current study set out to explore the awareness level and attitude of the general population of Hafr Al Batin, Saudi Arabia, where DM prevalence is high. METHODOLOGY: Data was collected through community-based, self-administered questionnaires in the general population of Hafr Al Batin, Saudi Arabia. The study included 406 participants, and the analysis revealed varying levels of knowledge, attitude, and practices related to DR. The study also explored the associations between sociodemographic factors and knowledge, attitude, and practices related to DR. The analysis showed that the participants had medium (67.4%) knowledge levels, while 32.5% had low knowledge.

resultsThe participants comprised 55.7% males and 44.3% females, with varying education levels and economic statuses. The majority were diagnosed with diabetes (94.3%). Attitude scores revealed that 30.8% had a favorable attitude, and 69.2% had medium attitude levels. Regarding practices, 71.2% of the respondents had low practice levels. The association between sociodemographic factors and knowledge, attitude, and practice were also explored.

conclusionThe current study concluded a medium level of knowledge (67.4%), and attitude toward DR is also low (69.2%). More than half of the respondents followed a poor level of practice (71.2%). The results of the current investigation demonstrated that the general population does not have sufficient knowledge, attitude, and practices regarding DR in Saudi Arabia. By promoting greater knowledge and understanding of DR, the burden of visual impairment brought on by this complication can be lessened by early detection and efficient care.

Indexed as

attitudediabetic retinopathyknowledgepracticesaudi arabia

Identifiers

PMID38084192
PMCPMC10710872
OpenAlexW4388562529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.